Fastly Sued For Securities Violations; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
28 mai 2024 19h21 HE
|
Block & Leviton LLP
Block & Leviton announces a securities fraud lawsuit has been filed against Fastly (NYSE: FSLY). Investors who have lost money should contact the firm.
BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology
28 mai 2024 08h00 HE
|
BranchOut Food Inc.
BranchOut Food Successfully Completes Key Tests with U.S. Army, Advancing MREs with GentleDry Technology
AmpliTech Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
24 mai 2024 16h05 HE
|
AmpliTech Group, Inc.
AmpliTech Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility
24 mai 2024 08h00 HE
|
BranchOut Food Inc.
BranchOut Food Inc. Secures Third EnWave Dehydration Machine; Announces $40M Production Capacity with New Peru Facility
JP 3E Holdings, Inc. Enters Agreement to Acquire Majority Stake in Bloxcross, Inc.
23 mai 2024 15h20 HE
|
JP 3E Holdings, Inc.
JP 3E Holdings, Inc. Enters Agreement to Acquire Majority Stake in Bloxcross, Inc.
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
23 mai 2024 07h00 HE
|
Sono-Tek Corporation
Sono-Tek Announces Fiscal Year 2024 Results with Record-Breaking Revenue and Record YOY Backlog
Formation Minerals, Inc. Announces Opportunistic Divestiture of Assets
22 mai 2024 08h00 HE
|
Formation Minerals, Inc.
Formation Minerals, Inc. Announces Opportunistic Divestiture of Assets
Neon Bloom Finalizes Terms to Acquire Advanced Executive Sales, LLC
21 mai 2024 17h59 HE
|
Neon Bloom Inc.
Neon Bloom Finalizes Terms to Acquire Advanced Executive Sales, LLC
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
21 mai 2024 12h35 HE
|
PRISM MarketView
PRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the Horizon
Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b
21 mai 2024 08h00 HE
|
Lipella Pharmaceuticals Inc.
Following Guidance from U.S. Food & Drug Administration in Type-C Meeting Lipella Pharmaceuticals to Advance Lead Product Candidate to Phase 2b